Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 4, 2014, Pages 455-463

  Zhang, Xuguang ^a   McGeoch, Susan C ^b   Johnstone, Alexandra M ^a   Holtrop, Grietje ^a   Sneddon, Alan A ^a   MacRury, Sandra M ^c   Megson, Ian L ^c   Pearson, Donald W M ^b   Abraham, Prakash ^b   De Roos, Baukje ^a   Lobley, Gerald E ^a   O'Kennedy, Niamh ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

Author keywords

Blood platelets; Cardiovascular diseases; Circulating cell derived microparticles; Obesity; Type 2 diabetes mellitus

Indexed keywords

FIBRINOGEN; PADGEM PROTEIN; THROMBOPLASTIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIET; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE MICROPARTICLE; LIFESTYLE; MALE; MEMBRANE MICROPARTICLE; MONOCYTE; MONOCYTE MICROPARTICLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; DIABETIC ANGIOPATHY; LEUKOCYTE COUNT; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; THROMBOCYTE;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; OBESITY; PLATELET ACTIVATION; RISK FACTORS;

EID: 84899680349     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-1000-2     Document Type: Article

References (50)

1. Garcia Rodriguez P, Eikenboom HC, Tesselaar ME, Huisman MV et al. (2010) Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. Thromb Res 126:345-349
2. Shet AS, Key NS, Hebbel RP (2004) Measuring circulating cell-derived microparticles. J Thromb Haemost 2:1848-1850
3. Shah MD, Bergeron AL, Dong JF, Lopez JA (2008) Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 19:365-372
4. Faure V, Dou L, Sabatier F, Cerini C et al. (2006) Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 4:566-573
5. Morel O, Morel N, Freyssinet JM, Toti F (2008) Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 19:9-23 (Pubitemid 351171554)
6. Mobarrez F, Antovic J, Egberg N, Hansson M et al. (2010) A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 125:e110-e116
7. Morel O, Ohlmann P, Morel N, Jesel L et al. (2005) Microparticles and cardiovascular disease. Arch Mal Coeur Vaiss 98:226-235
8. Amabile N, Guerin AP, Leroyer A, Mallat Z et al. (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16:3381-3388 (Pubitemid 46179341)
9. Koga H, Sugiyama S, Kugiyama K, Fukushima H et al. (2006) Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J 27:817-823
10. Tan KT, Tayebjee MH, Lim HS, Lip GY (2005) Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet Med 22:1657-1662 (Pubitemid 43046464)
11. Tan KT, Tayebjee MH, Macfadyen RJ, Lip GY, Blann AD (2005) Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation. Platelets 16:368-371 (Pubitemid 41491706)
12. Jy W, Minagar A, Jimenez JJ, Sheremata WA et al. (2004) Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci 9:3137-3144
13. Sabatier F, Darmon P, Hugel B, Combes V et al. (2002) Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51:2840-2845 (Pubitemid 34970939)
14. Toth B, Liebhardt S, Steinig K, Ditsch N et al. (2008) Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 100:663-669
15. Boulanger CM, Amabile N, Tedgui A (2006) Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 48:180-186 (Pubitemid 44309805)
16. Shantsila E (2009) Endothelial microparticles: a universal marker of vascular health? J Hum Hypertens 23:359-361
17. Jung KH, Chu K, Lee ST, Park HK et al. (2009) Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol 66:191-199
18. Cohen Z, Gonzales RF, Davis-Gorman GF, Copeland JG, McDonagh PF (2002) Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation. Thromb Res 107:217-221 (Pubitemid 35435379)
19. Kumanyika S, Jeffery RW, Morabia A, Ritenbaugh C et al. (2002) Obesity prevention: the case for action. Int J Obes Relat Metab Disord 26:425-436 (Pubitemid 34226170)
20. Eckel RH, Krauss RM (1998) American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee.Circulation 97:2099-2100 (Pubitemid 28262114)
21. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report (1998) National Institutes of Health. Obes Res 6(Suppl 2):51S-209S
22. Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415-445
23. Goichot B, Grunebaum L, Desprez D, Vinzio S et al. (2006) Circulating procoagulant microparticles in obesity. Diabetes Metab 32:82-85 (Pubitemid 43872600)
24. Ramacciotti E, Blackburn S, Hawley AE, Vandy F et al. (2011) Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost 17:425-431
25. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94:3791-3799
26. Ashcroft, B.A., de Sonneville, J., Yuana, Y., Osanto, S., et al. (2012) Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics. Biomed Microdevices 14(4):641-649
27. Wildman RP (2009) Healthy obesity. Curr Opin Clin Nutr Metab Care 12:438-443
28. Beck Nielsen H, Hother Nielsen O (2004) In: LeRoith D, Taylor SI, Olefsky JM (eds) Obesity in type 2 diabetes mellitus-diabetes mellitus: a fundamental and clinical text. Lippincott Williams & Wilkins, Philadelphia, pp 857-868
29. Murakami T, Horigome H, Tanaka K, Nakata Y et al. (2007) Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res 119:45-53 (Pubitemid 44716205)
30. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115:3378-3384 (Pubitemid 43121822)
31. Stec JJ, Silbershatz H, Tofler GH, Matheney TH et al. (2000) Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 102:1634-1638
32. Nieuwland R, Sturk A (2007) In: Michelson AD (ed) Platelet-derived microparticles-platelets. Academic Press, London, p 403
33. Key NS (2010) Analysis of tissue factor positive microparticles. Thromb Res 125(Suppl 1):S42-S45
34. Diamant M, Nieuwland R, Pablo RF, Sturk A et al. (2002) Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106:2442-2447 (Pubitemid 35278799)
35. Mann KG (2003) Thrombin formation. Chest 124:4S-10S
36. Morrissey JH (2004) Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol 79:103-108
37. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R (2003) Microparticles in cardiovascular diseases. Cardiovasc Res 59:277-287 (Pubitemid 37272022)
38. Evangelista V, Manarini S, Sideri R, Rotondo S et al. (1999) Platelet/polymorphonuclear leukocyte interaction: p-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 93:876-885 (Pubitemid 29067852)
39. Blann AD, Nadar SK, Lip GY (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24:2166-2179 (Pubitemid 37522669)
40. van der Zee PM, Biro E, Ko Y, de Winter RJ et al. (2006) P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 52:657-664
41. Lok CA, Nieuwland R, Sturk A, Hau CM et al. (2007) Micro-particle- associated P-selectin reflects platelet activation in preeclampsia. Platelets 18:68-72
42. Madonna R, De Caterina R (2011) Cellular and molecular mechanisms of vascular injury in diabetes - part I: pathways of vascular disease in diabetes. Vascul Pharmacol 54:68-74
43. Johnstone AM, Lobley GE, Horgan GW, BremnerDMet al. (2011) Effects of a high-protein, low-carbohydrate v. high-protein, moderate-carbohydrate weight-loss diet on antioxidant status, endothelial markers and plasma indices of the cardiometabolic profile. Br J Nutr 106(2):1-10
44. Arteaga RB, Chirinos JA, Soriano AO, Jy W et al. (2006) Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 98:70-74 (Pubitemid 43902682)
45. Langer HF, Chavakis T (2009) Leukocyte-endothelial interactions in inflammation. J Cell 13:1211-1220
46. Chironi G, Simon A, Hugel B, Del Pino M et al. (2006) Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol 26:2775-2780
47. Mallat Z, Benamer H, Hugel B, Benessiano J et al. (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101:841-843 (Pubitemid 30117876)
48. Omoto S, Nomura S, Shouzu A, Nishikawa M et al. (2002) Detection of monocyte-derived microparticles in patients with type II diabetes mellitus. Diabetologia 45:550-555 (Pubitemid 34533834)
49. Patil R, Ghosh K, Shetty S (2013) Profibrinolytic microparticles are not adequately produced to compensate their prothrombotic effect. Haematologica 98:e69
50. Lacroix R, Plawinski L, Robert S, Doeuvre L et al. (2012) Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis. Haematologica 97:1864-1872